Valuation: Seer, Inc.

Capitalization 11Cr 9.13Cr 8.47Cr 7.92Cr 15Cr 966.08Cr 16Cr 98Cr 39Cr 459.97Cr 40Cr 39Cr 1.68TCr P/E ratio 2025 *
-1.44x
P/E ratio 2026 * -1.39x
Enterprise value 11Cr 9.13Cr 8.47Cr 7.92Cr 15Cr 966.08Cr 16Cr 98Cr 39Cr 459.97Cr 40Cr 39Cr 1.68TCr EV / Sales 2025 *
6.25x
EV / Sales 2026 * 4.81x
Free-Float
88.51%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.05%
1 week-3.08%
Current month+3.28%
1 month+3.85%
3 months-12.50%
6 months-10.43%
Current year+3.28%
More quotes
1 week 1.85
Extreme 1.85
1.98
1 month 1.79
Extreme 1.79
1.99
Current year 1.8
Extreme 1.8
1.99
1 year 1.62
Extreme 1.62
2.44
3 years 1.46
Extreme 1.455
6.18
5 years 1.46
Extreme 1.455
85
10 years 1.46
Extreme 1.455
86.55
More quotes
Manager TitleAgeSince
Chief Executive Officer 57 01/03/2018
Director of Finance/CFO 58 01/05/2020
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 68 13/08/2024
Director/Board Member 70 01/12/2017
Director/Board Member 76 01/12/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.05%-3.08%-17.47%-64.74% 11Cr
-2.40%-1.65%+12.75%-5.13% 2.98TCr
-0.59%-2.12%-3.13%+12.74% 797.34Cr
+0.31%-.--%-.--%+8.44% 325.32Cr
-1.72%+0.27%+59.49% - 318.69Cr
-5.21%-11.42%-36.21%-64.27% 237.05Cr
-2.44%+8.69%-0.53%+54.45% 190.6Cr
-1.49%+0.62%+21.64%+20.45% 186.99Cr
+5.09%+18.65%+134.59%+128.93% 178.82Cr
+5.73%+8.35%-0.62%+116.22% 113.2Cr
Average -0.36%+3.67%+17.05%+23.01% 534.25Cr
Weighted average by Cap. -1.58%+0.79%+13.79%+6.39%
See all sector performances

Financials

2025 *2026 *
Net sales 1.7Cr 1.46Cr 1.35Cr 1.27Cr 2.36Cr 154.48Cr 2.53Cr 16Cr 6.17Cr 74Cr 6.38Cr 6.24Cr 268.78Cr 2.21Cr 1.9Cr 1.76Cr 1.65Cr 3.06Cr 200.82Cr 3.29Cr 20Cr 8.01Cr 96Cr 8.29Cr 8.12Cr 349.41Cr
Net income -7.58Cr -6.51Cr -6.04Cr -5.64Cr -11Cr -688.79Cr -11Cr -70Cr -27Cr -327.94Cr -28Cr -28Cr -1.2TCr -7.91Cr -6.79Cr -6.3Cr -5.89Cr -11Cr -718.77Cr -12Cr -73Cr -29Cr -342.22Cr -30Cr -29Cr -1.25TCr
Net Debt - -
More financial data * Estimated data
Logo Seer, Inc.
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.
Employees
134
More about the company
Date Price Change Volume
16/26/16 1.890 $ -1.05% 1,21,550
15/26/15 1.910 $ -0.52% 1,07,302
14/26/14 1.920 $ +0.52% 73,870
13/26/13 1.910 $ -2.05% 73,074

Delayed Quote Nasdaq, January 17, 2026 at 02:30 am IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.890
Average target price
-
Consensus

Quarterly revenue - Rate of surprise